How to detect early atherosclerosis ; focusing on techniques
|
|
- Gyles Holland
- 5 years ago
- Views:
Transcription
1 How to detect early atherosclerosis ; focusing on techniques Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon city, S. Korea
2 Surrogates for Atherosclerosis Measures of endothelial function Measures of arterial wall structure Generalized measures of inflammation
3 Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes (n=31) 198 patients with ACS Cardiovascular events cardiovascular death myocardial infarction ischemic stroke Assessment of systemic vasoreactivity provides important prognostic information Fichtlscherer S et al. Circulation. 2004;110:
4 Methods assessing endothelial function Invasive Coronary angiography using Doppler wire Strain guage plethysmography Noninvasive Flow-Mediated brachial artery Dilation first introduced in 1992 by Dr. Celermajer.
5 Basic principle of noninvasive method for testing endothelial function Endothelium Baseline Hyperemic Blood Flow Shear stress NO NO Vasodilatation NO PGI2(?) Hyperemia Normal Endothelial Dysfunction FMD (endothelial function), % = Hyperemic Diameter Baseline Diameter Baseline Diameter 100
6 Guidelines for FMD of the Brachial Artery (Subject preparation) Overnight fasting (8~12 hrs) A quiet, temperature-controlled room Medicine withheld for at least four half-lives, if possible Consider the subject`s mestrual cycle Affecting factors; temperature, food, drugs, sympathetic stimuli Corretti MC et al. JACC 2002;39:257-65
7 Changes of % diameter change (delta %) Superoxide anion formation (delta nmol/10 6 cells/min) Why Overnight Fasting? GROUP Low-fat High-fat y= 0.74x r= p= Changes of serum triglycerides (delta mg/dl) y= x r= P< y= x r= P< Changes of superoxide anion formation Changes of serum triglycerides (delta nmol/10 6 cells/min) (delta mg/dl) Bae JH et al. Atherosclerosis 2001;155:517-23
8 Changes of % diameter change (delta %) GROUP low fat high fat r = p = n = 18 y = x r = p = n = 17 y = x GROUP r = low fat p = high fat n = 17 y = 0.198x Changes of serum triglycerides (delta mg/dl) Changes of serum triglycerides (delta mg/dl)
9 Acute Effects of Vasoactive Drug on FMD SBP FMDNMD In Normal Subjects Measurements; Baseline and 3 hrs after medicine Holding 24hrs 3hr Recent administration of nonnitrate vasoactive drugs has no significant effects on FMD Gokce N et al. JACC 2002;40:761-5
10 Menstrual Cycle on FMD Phase... M F L Age, y 24.8± ± Body mass index, kg/m ± ± Total cholesterol, mmol/l 4.37± ± ± ±0.19 HDL cholesterol, mmol/l 1.63± ± ± ±0.08 LDL cholesterol, mmol/l 2.35± ± ± ±0.13 Triglyceride, mmol/l 1.94± ± ± ±0.10 Estradiol, pmol/l ± ± ± ± Progesterone, nmol/l 1.6± ± ± ±4.8 4 Endothelium-dependent vasodilatation varies during the menstrual cycle. The endogenous estradiol may be involved in this menstrual cycle related vasodilatation. Gokce N et al. JACC 2002;40:761-5
11 Guidelines for FMD of the Brachial Artery (Equipment) Vascular software (2D-imaging, color and spectral Doppler, an internal ECG monitor) and a high-frequency vascular transducer) For sufficient resolution, a minimum frequency of 7 MHz Image resolution is enhanced with broad-band (7 to 12 MHz) Corretti MC et al. JACC 2002;39:257-65
12 Guidelines for FMD of the Brachial Artery (Image Acquisition) Cross-sectional imaging ; can not be used ; inadequate lat wall definition ; skew artifact M mode and A mode (wall tracking) ; more error owing to tracking drift Anatomic landmarks ; veins and fascial planes Corretti MC et al. JACC 2002;39:257-65
13 Guidelines for FMD of the Brachial Artery (Endothelium-dependent FMD) To create a flow stimulus in the brachial artery Baseline 5 minutes of upper (lower) arm arterial occlusion s after cuff deflation Hyperemic Baseline diameter Blood flow by PW Doppler Velocity signal Cuff inflation; at least 50mmHg above SBP Ischemia and consequent dilation of downstream resistance vessel via autoregulation Corretti MC et al. JACC 2002;39:257-65
14 Guidelines for FMD of the Brachial Artery (Endothelium-dependent FMD) Position of cuff inflation; no concensus On the upper arm; Greater percent change in diameter due to a greater flow stimulus resulting from recruitment of more resistance vessels or to direct effects of ischemia on the brachial artery Less reliable due to image distortion by collapse of the brachial artery and shift in soft tissue Corretti MC et al. JACC 2002;39:257-65
15 Guidelines for FMD of the Brachial Artery (Endothelium-dependent FMD) Duration of cuff inflation The change of BA diameter increases as the duration of cuff inflation increases from 30 s to 5 min. The change in diameter is similar after 5 and 10 min of occlusion. Therefore, the more easily tolerated 5-min occlusion Corretti MC et al. JACC 2002;39:257-65
16 Guidelines for FMD of the Brachial Artery (Endothelium-dependent FMD) Measurement of hyperemic flow in hyperemic phase 5 minutes of upper (lower) arm arterial occlusion Hyperemic Flow; no later than 15 s after deflation Hashimoto M et al. J Pharmacol Sci. 2003;93:405-8.
17 Guidelines for FMD of the Brachial Artery (Endothelium-dependent FMD) Measurement of BA diameter in hyperemic phase 5 minutes of upper (lower) arm arterial occlusion s after cuff deflation Hyperemic Why s after cuff deflation Image of BA in hyperemic phase; recording continuously from 30 s before to 2 min after deflation Most studies; 1 min after cuff deflation Corretti MC et al. JACC 2002;39:257-65
18 Guidelines for FMD of the Brachial Artery (Endothelium-dependent FMD) FMD Why brachial artery? Arteries <2.5mm in diameter; difficult to measure Baseline BA diameter (Radial artery) 6 r= p<0.001 n= Arteries >5.0mm in diameter; FMD is less difficult to perceive (Femoral artery)
19 Baseline Hyperemic FMD= 100 Hyper BAD-Base BAD Base BAD
20 FMD, in general Bots ML et al. EHJ 2005;26:363-8
21 Guidelines for NMD of the Brachial Artery (Endothelium-independent vasodilation with NTG) Test sequence Baseline 4 min after NTG At least 10 min rest after FMD Exogenous NO donor Single high dose (0.4mg) Spray or SL NTG Peak vasodilation (3-4 min) Image; continuous recording 3-4 min after NTG To measure max vasodilatory response Reflecting vascular smooth m function Corretti MC et al. JACC 2002;39:257-65
22 Guidelines for NMD of the Brachial Artery (Endothelium-independent vasodilation with NTG) Dose-response Max vasodilatory response at the plateau similar The dose required to produce 50% of the max response - greater in patients (p<0.002) (181ug vs.115ug) Most previous studies ; impaired FMD in atherosclerotic Pt but preserved NMD however, FMD associated with NMD Impaired dilator response to NTG in CAD Pt; smooth m dysfunction Raitakari OT et al. AJC 2001;87:217-9
23 Korean IMT Study Normal Risk Factor Total n=227 Total n= ± ± ± p<0.001 p= ± ± ± ± ± ± ± ±0.10 p=0.197 p=0.912 p=0.334 SEX female ±0.1 p= N = Age (yrs) 44 35~ ~ ~64 male.5 N = Age (yrs) 31 35~ ~ ~64 Bae JH et al. Korean Society of Hypertension (supp) 2004:124-5
24 Cumulative Event-Free Rate (%) Systemic Atherosclerosis: Carotid Disease as a Marker of CV Risk Cumulative Event-Free Rates for MI or Stroke, According to Quintile of Combined IMT (n=4476), 65 years of age or older st Quintile IMT 2nd Quintile IMT 3rd Quintile IMT 4th Quintile IMT Years 5th Quintile IMT O Leary et al. N Engl J Med. 1999;340:14-22.
25 Carotid IMT AHA recommendation for evaluation of risk in primary prevention out of the various noninvasive imaging ; Carotid intima-media thickness (IMT) Carotid IMT ; independent assessment of coronary risk ;independent predictor of coronary events in patients with CAD. Smith SC et al. AHA conference proceedings. 2000;101: Chan SY et al. J Am Coll Cardiol 2003;42:
26 Measures of Arterial Wall Intima Media Thickness (QIMT) Safe standardized and validated method Direct assessment of disease Reproducible Easy to learn Relatively inexpensive
27 Measures of Arterial Wall CLAS colestipol and niacin IMT 1cm below bulb is (1994) reproducible and has correlation with CV events MARS lovastatin confirmed above (1994) PLAC II pravastatin established that the most (1995) reliable part to measure is the far wall of the common carotid
28 Manual measurement of carotid IMT 1 cm CCA
29 Example of carotid plaque
30 IMT : Semi Automatic Measurement
31 Background of Korean software (KS) development for IMT measurement Good detection Poor detection
32 Korean software (KS) for IMT measurement
33 Korean software (KS) for IMT measurement
34
35 Korean software for IMT measurement Number Age Sex (M/F) Height (cm) Weight (kg) BMI HBP DM Hyperlipidemia Smoking Diagnosis No atherosclerotic disease Patients with risk factors Atherosclerotic disease Total cholesterol (mg/dl) Triglyceride (mg/dl) HDL-cholesterol (mg/dl) LDL-cholesterol (mg/dl) Random glucose (mg/dl) Uric acid (mg/dl) BUN (mg/dl) Creatinine (mg/dl) Subjects: 60 consecutive subjects undergoing routine TTE IMT: by M`ATH (blinded examiner) by Korean software (KRISS) Compare Pearson correlation coefficients between age and the data of M`ATH and Korean software
36 IMT by M`ATH IMT by KS Korean software (KS) for IMT measurement y= x r=0.616 p<0.001 n= y= x r=0.537 p<0.001 n= Age (yrs) Age (yrs) Comparison of Pearson correlation coefficients by both methods
37 Intima thickness by KS Media thickness by KS Korean software for IMT measurement y= x r=0.507 p<0.05 n= Age (yrs) Age (yrs) Correlation between age and intima or media thickness
38 FMD, IMT, and PWV 8 7 p= p= p= N = 18 normal p= risk factor CAD.7 N = 18 normal 15 risk factor 43 CAD N = 18 normal 16 p=0.023 risk factor 43 CAD Age- and sex- matched study population Bae JH et al. Korean Circulation J 2004;34:845-55
39 FMD, IMT, and PWV 10 n=75 p=0.007 r= n=76 p=0.000 r= n=76 p=0.007 r= PWV (cm/sec) PWV (cm/sec) Bae JH et al. Korean Circulation J 2004;34: FMD (%) These are related to each other, the combination of these measurement will be of stronger clinical relevance 8 10
40 In Conclusion FMD, IMT, and PWV are functional and structural surrogates of the atherosclerotic process. Limitations of FMD; variable reproducibility, influenced by exogenous factors. Future; need to reveal an association of improvement in response to treatment with improvement in prognosis
41 The Relative Importance of Vascular Structure and Function in Predicting Cardiovascular Events Kaplan-Meier curves for event-free survival IMT LV Mass FMD <0.62mm >0.71mm <181g >276g >6.3% <2% CV events; death, MI, admission with ACS, stroke, revascularization 444 patients with CAD, dialysis, or multiple risk factors Follow-up; 24 months IMT was the independent vascular factor for mortality, even in the subgroup with no CAD and low risk. Fathi R et al. J Am Coll Cardiol 2004;43:616-23
42 FMD (%) Can We Restore the Endothelial Dysfunction in Patients with Essential Hypertension with Calcium Channel Blockers? P< P<0.001 NS 15 P< Control HBP CAD Baseline Follow up Bae JH et al. Korean Circulation J 2000;30:1010-6
43 The Difference of Endothelial Function According to the Presence of Restenosis in Patients Undergoing PCI P= Restenosis Patent Bae JH et al. Korean Circulation J 2001;31:
44 Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. 136 patients undergoing stenting ISR; 20 pts (15%) Patti G et al. Circulation 2005;11:7005
45 Time Sequence of Atherosclerosis Surrogates Abnormality 31 diabetic children (15 yrs old, 6.8 yrs DM duration), 35 age-matched healthy children No difference in carotid IMT Endothelial dysfunction precedes an increase in carotid IMT Singh TP et al. J Am Coll Cardiol 2003;41:661-5
46 FMD (%) IMTcca (mm) Time Sequence of the Improvement of Atherosclerosis Surrogates Abnormality P=0.008 P= P=0.435 P= Statins Control 0.5 Statins Control 105 statin group and 100 control group undergoing stenting 6 months follow up Statin improves endothelial dysfunction, not carotid IMT in patients undergoing stenting Bae JH et al. J Cardiovasc Pharmacol Ther. 2004;9:185-92
Coronary artery disease (CAD) risk factors
Background Coronary artery disease (CAD) risk factors CAD Risk factors Hypertension Insulin resistance /diabetes Dyslipidemia Smoking /Obesity Male gender/ Old age Atherosclerosis Arterial stiffness precedes
More informationA study of brachial artery flow mediated dilatation and carotid intima media thickness in subjects having risk factors for coronary artery disease
International Journal of Advances in Medicine http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20171037 A study of brachial
More informationPrognostic Value of Brachial Artery Endothelial Function and Wall Thickness
Journal of the American College of Cardiology Vol. 46, No. 6, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.05.070
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationImaging Biomarkers: utilisation for the purposes of registration. EMEA-EFPIA Workshop on Biomarkers 15 December 2006
Imaging Biomarkers: utilisation for the purposes of registration EMEA-EFPIA Workshop on Biomarkers 15 December 2006 Vascular Imaging Technologies Carotid Ultrasound-IMT IVUS-PAV QCA-% stenosis 2 ICH E
More informationEffects of Statins on Endothelial Function in Patients with Coronary Artery Disease
Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Iana I. Simova, MD; Stefan V. Denchev, PhD; Simeon I. Dimitrov, PhD Clinic of Cardiology, University Hospital Alexandrovska,
More informationReceived: March 2008; in final form May 2008.
RELATIONSHIP BETWEEN BRACHIAL ARTERY FLOW- MEDIATED DILATION AND CAROTID ARTERY INTIMA MEDIA THICKNESS IN THE MIDDLE-AGED SUBJECTS WITH LOW CARDIOVASCULAR RISK GERMAINE SĂVOIU*, LAVINIA NOVEANU**, O. FIRA-MLADINESCU*,
More informationWhich CVS risk reduction strategy fits better to carotid US findings?
Which CVS risk reduction strategy fits better to carotid US findings? Dougalis A, Soulaidopoulos S, Cholongitas E, Chalevas P, Vettas Ch, Doumtsis P, Vaitsi K, Diavasti M, Mandala E, Garyfallos A 4th Department
More informationAN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE
AN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE Good for your patients. Good for your practice. Using the AngioDefender system to complement your patients care routine enables you to: Improve your patient
More informationCho et al., 2009 Journal of Cardiology (2009), 54:
Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal
More informationDyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram
Dyslipidaemia Is there any new information? Dr. A.R.M. Saifuddin Ekram PhD,FACP,FCPS(Medicine) Professor(c.c.) & Head Department of Medicine Rajshahi Medical College Rajshahi-6000 New features of ATP III
More informationIntima-Media Thickness
European Society of Cardiology Stockholm, 30th August 2010 Intima-Media Thickness Integration of arterial assessment into clinical practice Prof Arno Schmidt-Trucksäss, MD Institute of Exercise and Health
More informationLifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study
Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study Harvey White Green Lane Cardiovascular Service and Cardiovascular
More informationChest Pain in Women ;What is Your Diagnostic Plan? No Need for Noninvasive Test
Chest Pain in Women ;What is Your Diagnostic Plan? No Need for Noninvasive Test Jang-Ho Bae, MD., PhD., FACC. Konyang University Hospital Daejeon, Korea Chest pain in Women ACS Atypical Stable angina F/29
More informationDiabetes, Insulin Resistance and Atherosclerosis Surrogates in Patients With Coronary Atherosclerosis
ORIGINAL ARTICLE DOI 10.4070 / kcj.2010.40.2.62 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2010 The Korean Society of Cardiology Open Access Diabetes, Insulin Resistance and Atherosclerosis
More informationCOURAGE to Leave Diseased Arteries Alone
COURAGE to Leave Diseased Arteries Alone Spencer King MD MACC, FSCAI St. Joseph s s Heart and Vascular Institute Professor of Medicine Emeritus Emory Univ. Atlanta, USA Conflict: I am an Interventionalist
More informationAtherosclerosis Regression An Overview of Recent Findings & Issues
Atherosclerosis Regression An Overview of Recent Findings & Issues 13th Angioplasty Summit 2008 Cheol Whan Lee, MD University of Ulsan, Asan Medical Center, Seoul, Korea CardioVascular Research Foundation
More informationCorrelation of novel cardiac marker
Correlation of novel cardiac marker and mortality in EGAT population. Soluble ST2 hscrp Poh Chanyavanich, MD SukitYamwong, MD Piyamitr Sritara, MD Ramathibodi hospital Background hscrp - the most widely
More informationSubclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD
Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.
More informationEndothelial Function Assessment in Secondary Prevention
Endothelial Function Assessment in Secondary Prevention Amir Lerman, MD Professor of Medicine Chair for Research Cardiovascular Division 2014 MFMER 3319523-1 Multiple Risk Factors 58-y.o. man with CV risk
More informationΛΟΙΜΩΞΗ HIV. Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική
ΛΟΙΜΩΞΗ HIV Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική Κλινική, Νοσοκομείο «Αττικόν» Infection Acute Myocardial Infarction p er 100,000 HIV/AIDS discharg es 800 700 600 500 400 300 200
More informationMPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola
MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Quanta Diagnostico Nuclear Curitiba, Brazil Clinical history Male 63 y.o.,
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationNomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure
801 Original Article Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure Akira YAMASHINA, Hirofumi TOMIYAMA, Tomio ARAI, Yutaka KOJI, Minoru YAMBE, Hiroaki MOTOBE, Zydem
More informationEndothelial function is impaired in women who had pre-eclampsia
Endothelial function is impaired in women who had pre-eclampsia Christian Delles, Catriona E Brown, Joanne Flynn, David M Carty Institute of Cardiovascular and Medical Sciences University of Glasgow United
More informationHypothesis: When compared to conventional balloon angioplasty, cryoplasty post-dilation decreases the risk of SFA nses in-stent restenosis
Cryoplasty or Conventional Balloon Post-dilation of Nitinol Stents For Revascularization of Peripheral Arterial Segments Background: Diabetes mellitus is associated with increased risk of in-stent restenosis
More informationPrevalence and Significance of Carotid Plaques in Patients With Coronary Atherosclerosis
ORIGINAL ARTICLE DOI 10.4070 / kcj.2009.39.8.317 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2009 The Korean Society of Cardiology Prevalence and Significance of Carotid Plaques in Patients
More informationBackground. Metabolic syndrome T2DM CARDIOVASCULAR DISEASE. Major Unmet Clinical Need. Novel Risk Factors. Classical Risk Factors LDL-C.
The effect of metabolic syndrome for left ventricular geometry, arterial stiffness and carotid intima-media thickness in Korean general population Result from Atherosclerosis RIsk of Rural Area in Korea
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationEndothelial dysfunction and the role of hypertension in Nepalese subjects with major coronary risk factors
Original Article Endothelial dysfunction and the role of hypertension in Nepalese subjects with major coronary risk factors Mani Prasad Gautam, 1 Samir Gautam, 2 Usha Ghimire, 3 Sogunuru Guruprasad, 4
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationReview of guidelines for management of dyslipidemia in diabetic patients
2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University
More informationMaria Angela S. Cruz-Anacleto, MD
Maria Angela S. Cruz-Anacleto, MD 57/Female Menopausal Non-HTN, non-dm Hypothyroid (s/p RAI 1997) Levothyroxine 100 ug OD 5 Months PTA Chest discomfort Stress Echocardiography 5 Months PTA Chest discomfort
More informationRelationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases
Relationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases Introduction Reactive oxygen species (ROS),such as superoxide and
More informationCase Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer
Case Presentation Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation 50 YO man NSTEMI treated with PCI 1 month ago Medical History: Obesity: BMI 32,
More informationMetabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI
Metabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI Narbeh Melikian*, Ajay M Shah*, Martyn R Thomas, Roy Sherwood, Mark T
More informationΠρώιμη αγγειακή γήρανση στην υπέρταση: διάγνωση και αντιμετώπιση
Πρώιμη αγγειακή γήρανση στην υπέρταση: διάγνωση και αντιμετώπιση Χαράλαμπος Βλαχόπουλος 1 η Καρδιολογική Κλινική Πανεπιστημίου Αθηνών Ιπποκράτειο Γ.Ν.Α. Οι προβλεπόμενες αρτηριακές αλλαγές με βάση την
More informationBrachial artery hyperemic blood flow velocities are related to carotid atherosclerosis Susann J. Järhult, Johan Sundström and Lars Lind
Clin Physiol Funct Imaging (29) doi: 1.1111/j.1475-97X.29.879.x Brachial artery hyperemic blood flow velocities are related to carotid atherosclerosis Susann J. Järhult, Johan Sundström and Lars Lind Department
More informationEnvironmental. Vascular / Tissue. Metabolics
Global Risk Reduction--WINS Picking Mom and Dad-2016 Environmental Vascular / Tissue Metabolics Stop smoking-1b Physical activity-1b Weight control-1b Chelation therapy-3c Influenza vaccination-1b Blood
More informationAnnals of RSCB Vol. XIV, Issue 1
THE ROLE OF URIC ACID AS A RISK FACTOR FOR ARTERIAL HYPERTENSION Corina Şerban 1, Germaine Săvoiu 2, Lelia Şuşan 3, Alina Păcurari 3, A. Caraba 3, Anca Tudor 4, Daniela Ionescu 5, I. Romosan 3, A. Cristescu
More informationDyslipidemia in the light of Current Guidelines - Do we change our Practice?
Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease
More informationsurtout qui n est PAS à risque?
3*25 min et surtout qui n est PAS à risque? 2018 ESC/ESH Hypertension Guidelines 2018 ESC-ESH Guidelines for the Management of Arterial Hypertension 28 th ESH Meeting on Hypertension and Cardiovascular
More informationCAROTID INTIMA-MEDIA THICKNESS. Dimitrios N. Nikas, MD, PhD, FESC Interventional Cardiologist Ioannina University Hospital
CAROTID INTIMA-MEDIA THICKNESS Dimitrios N. Nikas, MD, PhD, FESC Interventional Cardiologist Ioannina University Hospital I, DIMITRIOS N. NIKAS, MD, PHD, FESC, HAVE NO CONFLICT OF INTEREST TO DECLARE RELATED
More information2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center
2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium Does Lt Late Cth Catch up Exist Eiti in DES? : Quantitative Coronary Angiography Analysis Kyung Woo Park, MD Cardiovascular
More informationDiabetes and the Heart
Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital
More information21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease
21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease Noninvasive Evaluation of Coronary Artery Disease: Anatomical, Functional, Clinical May 5, 2018 Mark Hansen MD FRCPC Cardiologist,
More informationPractical challenges in CV risk management: When to start intervening in CVD?
The National Research Center for Preventive Medicine Ministry of Healthcare, Russian Federation Practical challenges in CV risk management: When to start intervening in CVD? Prof. Drapkina O.M., Eliashevich
More informationSFRBM Annual Meeting, Pre-meeting Workshop II Flavanols in Health and Disease
FLAVIOLA Targeted delivery of dietary flavanols for optimal human cell function: Effects on cardiovascular health SFRBM Annual Meeting, Pre-meeting Workshop II Flavanols in Health and Disease Flavanol
More informationAcute Effects of Vasoactive Drug Treatment on Brachial Artery Reactivity
Journal of the American College of Cardiology Vol. 40, No. 4, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)02034-X
More informationNew Guidelines in Dyslipidemia Management
The Fourth IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk Muscat, Oman, February 2018 New Guidelines in Dyslipidemia Management Dr. Khalid Al-Waili, MD, FRCPC, DABCL Senior Consultant Medical
More informationCurrent and Future Imaging Trends in Risk Stratification for CAD
Current and Future Imaging Trends in Risk Stratification for CAD Brian P. Griffin, MD FACC Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Disclosures: None Introduction
More informationPreclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD
Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD 1 Preclinical? No symptoms No physical findings No diagnostic ECG findings No chest X-ray X findings No diagnostic events 2
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationSTUDIES ON ARTERIAL ENDOTHELIAL FUNCTION AND INTIMA- MEDIA THICKNESS USING ULTRASOUND TECHNIQUE. Morteza Rohani
STUDIES ON ARTERIAL ENDOTHELIAL FUNCTION AND INTIMA- MEDIA THICKNESS USING ULTRASOUND TECHNIQUE Morteza Rohani Stockholm 2008 DEPARTMENT OF MEDICINE, HUDDINGE KAROLINSKA INSTITUTET, STOCKHOLM, SWEDEN STUDIES
More informationCLINICAL OUTCOME Vs SURROGATE MARKER
CLINICAL OUTCOME Vs SURROGATE MARKER Statin Real Experience Dr. Mostafa Sherif Senior Medical Manager Pfizer Egypt & Sudan Objective Difference between Clinical outcome and surrogate marker Proper Clinical
More informationEndothelial function and left ventricular remodeling in diabetic and non-diabetic patients after acute coronary syndrome
Med Sci Monit, 2011; 17(2): 73-77 PMID: 21278691 WWW.MEDSCIMONIT.COM Clinical Research Received: 2010.05.10 Accepted: 2010.08.09 Published: 2011.02.01 Endothelial function and left ventricular remodeling
More informationPHENOTYPING FAMILIES OF A HYPERTENSIVE PATIENT
PHENOTYPING FAMILIES OF A HYPERTENSIVE PATIENT Christian Delles BHF Glasgow Cardiovascular Research Centre Advantages Cardiovascular of a Family-based ContinuumDesign Related subjects are more likely to
More informationNew Insight about FFR and IVUS MLA
New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR
More informationJanet B. Long, MSN, ACNP, CLS, FAHA, FNLA Rhode Island Cardiology Center
Primary and Secondary Prevention of Coronary Artery Disease: What is the role of non statin drugs (fenofibrates, fish oil, niacin, folate and vitamins)? Janet B. Long, MSN, ACNP, CLS, FAHA, FNLA Rhode
More informationArterial stiffness index: A new evaluation for arterial stiffness in elderly patients with essential hypertension
Blackwell Science, LtdOxford, UK GGIGeriatrics and Gerontology International1444-15862002 Blackwell Science Asia Pty Ltd 24December 2002 045 ASI in elderly hypertensive patients M Kaibe et al. 10.1046/j.1444-1586.2002.00045.x
More informationCurrent Role of Renal Artery Stenting in Patients with Renal Artery Stenosis
Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Etiology Fibromuscular
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationValue of carotid intimal medial thickness as independent predictor of endothelial dysfunction in uremic patients
The Egyptian Heart Journal (211) 63, 73 7 Egyptian Society of Cardiology The Egyptian Heart Journal www.elsevier.com/locate/ehj www.sciencedirect.com ORIGINAL ARTICLE Value of carotid intimal medial thickness
More informationIncreased nitroglycerin mediated vasodilation in migraineurs without aura in the interictal period
Journal of Medical Ultrasonics (2018) 45:605 610 https://doi.org/10.1007/s10396-018-0880-3 ORIGINAL ARTICLE Increased nitroglycerin mediated vasodilation in migraineurs without aura in the interictal period
More informationIn-Ho Chae. Seoul National University College of Medicine
The Earlier, The Better: Quantum Progress in ACS In-Ho Chae Seoul National University College of Medicine Quantum Leap in Statin Landmark Trials in ACS patients Randomized Controlled Studies of Lipid-Lowering
More informationPredictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis
Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis Tadeusz Przewlocki, Anna Kablak Ziembicka, Piotr Pieniazek,
More informationPeripheral Arterial Disease. Westley Smith MD Vascular Fellow
Peripheral Arterial Disease Westley Smith MD Vascular Fellow Background (per 10,000) Goodney P, et al. Regional intensity of vascular care and lower extremity amputation rates. JVS. 2013; 6: 1471-1480.
More informationAPPLICATION OF PHYSICAL METHODS FOR DETERMINATION OF FUNCTIONAL PARAMETERS OF ARTERIES IN RHEUMATIC PATIENTS
APPLICATION OF PHYSICAL METHODS FOR DETERMINATION OF FUNCTIONAL PARAMETERS OF ARTERIES IN RHEUMATIC PATIENTS Jolanta DADONIENE*, Alma CYPIENE**, Diana KARPEC***, Rita RUGIENE*, Sigita STROPUVIENE*, Aleksandras
More informationChoosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease. Greg Wellenius Joel Kaufman
Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease Greg Wellenius Joel Kaufman Framework for Choosing Subclinical Outcomes To Study What clinical outcomes
More informationCoronary microvascular dysfunction after elective percutaneous coronary intervention: correlation with exercise stress test results
Department of Cardiovascular Medicine Università Cattolica del Sacro Cuore Rome, Italy Coronary microvascular dysfunction after elective percutaneous coronary intervention: correlation with exercise stress
More informationEffects of Kidney Disease on Cardiovascular Morbidity and Mortality
Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Joachim H. Ix, MD, MAS Assistant Professor in Residence Division of Nephrology University of California San Diego, and Veterans Affairs
More informationTheoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.
Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. TensioMed Arterial Stiffness Centre, Budapest Heart Institute, Faculty of Medicine, University of Pécs
More informationEffect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators
More informationConduit Artery Constriction Mediated by Low Flow
Journal of the American College of Cardiology Vol. 51, No. 20, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.01.049
More informationRole of imaging in risk assessment models: the example of CIMT
Role of imaging in risk assessment models: the example of CIMT Diederick E. Grobbee, MD, PhD, FESC Professor of Clinical Epidemiology Julius Center for Health Sciences and Primary Care, University Medical
More informationThe Clinical Unmet need in the patient with Diabetes and ACS
The Clinical Unmet need in the patient with Diabetes and ACS Professor Kausik Ray (UK) BSc(hons), MBChB, MD, MPhil, FRCP (lon), FRCP (ed), FACC, FESC, FAHA Diabetes is a global public health challenge
More informationegfr > 50 (n = 13,916)
Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according
More informationDivision of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan
Association between continuously elevated C-reactive protein and restenosis after percutaneous coronary intervention using drug-eluting stent in angina patients Division of Cardiovascular Medicine, Jichi
More informationThe Impact Of Adiposity And Insulin Resistance On Endothelial Function In Middle-Aged Subjects
ISPUB.COM The Internet Journal of Cardiovascular Research Volume 1 Number 1 The Impact Of Adiposity And Insulin Resistance On Endothelial Function In Middle-Aged Subjects L Zhu, K Liu Citation L Zhu, K
More informationHeart Online First, published on March 29, 2005 as /hrt SCIENTIFIC LETTER
Heart Online First, published on March 29, 2005 as 10.1136/hrt.2004.056523 Manuscript ID: HEARTJNL/2004/056523 March 18, 2005 SCIENTIFIC LETTER Effects of HMG-CoA Reductase Inhibition on Endothelial Function
More informationAngioDefender. A man is as old as his arteries. Dr. Thomas Sydenham, British physician ( ) known as the English Hippocrates
AngioDefender A man is as old as his arteries Dr. Thomas Sydenham, British physician (1624-1689) known as the English Hippocrates Since the dawn of modern clinical medicine, when patient observation and
More informationEvidence-Based Management of CAD: Last Decade Trials and Updated Guidelines
Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict
More informationThe Diabetes Link to Heart Disease
The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM
More informationMicrovascular Disease: How to Diagnose and What s its Treatment
Microvascular Disease: How to Diagnose and What s its Treatment Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of
More informationHow to Evaluate Microvascular Function and Angina. Myeong-Ho Yoon Ajou University Hospital
How to Evaluate Microvascular Function and Angina Myeong-Ho Yoon Ajou University Hospital Angina without Coronary Artery Disease (CAD) Prevalence: 20-30% going c-angiography, with a higher prevalence (almost
More informationWomen and Coronary Artery Disease:
Women and Coronary Artery Disease: Less is More? Interventional Cardiology 2017 32 th Annual International Symposium Snow Mass March 5-10 Yolande Appelman MD, PhD,FESC EAPCI-Women Interventional Cardiologist
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationPut your Heart before your Head
Put your Heart before your Head Alok K Gupta, MD, FAAFP, FASH Associate Professor, Outpatient Clinic since 1963, the US Congress has required the President to proclaim February "American Heart Month."
More informationSTATINS FOR PAD Long - term prognosis
STATINS FOR PAD Long - term prognosis Prof. Pavel Poredos, MD, PhD Department of Vascular Disease University Medical Centre Ljubljana Slovenia DECLARATION OF CONFLICT OF INTEREST No conflict of interest
More informationAdults With Diagnosed Diabetes
Adults With Diagnosed Diabetes 1990 No data available Less than 4% 4%-6% Above 6% Mokdad AH, et al. Diabetes Care. 2000;23(9):1278-1283. Adults With Diagnosed Diabetes 2000 4%-6% Above 6% Mokdad AH, et
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationManagement of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018
Management of Stable Ischemic Heart Disease Vinay Madan MD February 10, 2018 1 Disclosure No financial disclosure. 2 Overview of SIHD Diagnosis Outline of talk Functional vs. Anatomic assessment Management
More informationSection 03: Pre Exercise Evaluations and Risk Factor Assessment
Section 03: Pre Exercise Evaluations and Risk Factor Assessment ACSM Guidelines: Chapter 3 Pre Exercise Evaluations ACSM Manual: Chapter 3 Risk Factor Assessments HPHE 4450 Dr. Cheatham Purpose The extent
More informationPotential Applications:
How To Vascular Function in Animal and Clinical Study Yeungnam Univ. Hospital Jong-Seon Park, MD, PhD Vascular Function Test, When? Potential Applications: Identification of cardiovascular risk (e.g. patient
More informationAbstract nr AHA, Chicago November European Heart Journal Cardiovascular Imaging, in press. Nr Peter Blomstrand
Left Ventricular Diastolic Function Assessed by Echocardiography and Tissue Doppler Imaging is a strong Predictor of Cardiovascular Events in Patients with Diabetes Mellitus Type 2 Peter Blomstrand, Martin
More informationFRACTIONAL FLOW RESERVE USE IN THE CATH LAB BECAUSE ANGIOGRAPHY ALONE IS NOT ENOUGH!!!!!!!!
FRACTIONAL FLOW RESERVE USE IN THE CATH LAB BECAUSE ANGIOGRAPHY ALONE IS NOT ENOUGH!!!!!!!! Juan Antonio Pastor-Cervantes,M.D FSCAI, FACC Cardiovascular Institute Memorial Regional Hospital Hollywood Florida
More informationStatin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,
More informationLandmesser U et al. Eur Heart J 2017; https://doi.org/ /eurheartj/ehx549
2017 Update of ESC/EAS Task Force on Practical Clinical Guidance for PCSK9 inhibition in Patients with Atherosclerotic Cardiovascular Disease or in Familial Hypercholesterolaemia Cardiovascular Outcomes
More information